Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine

Journal of Feline Medicine and Surgery

Volumn 11, Issue 8, 2009, Pages 668-682

  Roomp, Kirsten ^a   Rand, Jacquie ^b  

^a MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; CARBOHYDRATE DIET; CAT; CAT DISEASE; COMORBIDITY; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

ANIMALS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CAT DISEASES; CATS; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; FEMALE; GERMANY; HYPOGLYCEMIC AGENTS; INSULIN; MALE; TREATMENT OUTCOME;

EID: 67650702582     PISSN: 1098612X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfms.2009.04.010     Document Type: Article

References (34)

1. DCCT Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329 (1993) 977-986
2. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
3. Garfield S.A., Malozowski S., Chin M.H., et al. Considerations for diabetes translational research in real-world settings. Diabetes Care 26 (2003) 2670-2674
4. Martin G., and Rand J. Current understanding of feline diabetes: part 2, treatment. J Feline Med Surg 2 (2000) 3-17
5. Martin G.J., and Rand J.S. Control of diabetes mellitus in cats with porcine insulin zinc suspension. Vet Rec 161 (2007) 88-94
6. Marshall R.D., Rand J.S., and Morton J.M. Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. J Vet Pharmacol Ther 31 (2008) 205-212
7. Marshall R.D., and Rand J. Treatment with glargine results in higher remission rates than lente or protamine zinc insulins in newly diagnosed diabetic cats (2005), ACVIM, Baltimore, Maryland, USA 36
8. Martin G.J., and Rand J.S. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy. J Feline Med Surg 3 (2001) 23-30
9. Meneghini L., Koenen C., Weng W., et al. The usage of a simplified self-titration dosing guideline (303 algorithm) for insulin detemir in patients with type 2 diabetes - results of the randomized, controlled predictive 303 study. Diabetes Obes Metab 9 (2007) 902-913
10. Davies M., Lavalle-Gonzalez F., Storms F., et al. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes Obes Metab 10 (2008) 387-399
11. Selam J.L., Koenen C., Weng W., et al. Improving glycemic control with insulin detemir using the 303 algorithm in insulin naive patients with type 2 diabetes: a subgroup analysis of the US Predictive 303 study. Curr Med Res Opin 24 (2008) 11-20
12. Rand J.S., and Marshall R.D. Diabetes mellitus in cats. Vet Clin North Am Small Anim Pract 35 (2005) 211-224
13. Bennett N., Greco D.S., Peterson M.E., et al. Comparison of a low carbohydrate-low fiber diet and a moderate carbohydrate-high fiber diet in the management of feline diabetes mellitus. J Feline Med Surg 8 (2006) 73-84
14. Hoenig M., Thomaseth K., Waldron M., et al. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 292 (2007) R227-R234
15. Rand J.S., Fleeman L.M., Farrow H.A., et al. Canine and feline diabetes mellitus: nature or nurture?. J Nutr 134 (2004) 2072S-2080S
16. Zoran D.L. The carnivore connection to nutrition in cats. J Am Vet Med Assoc 221 (2002) 1559-1567
17. Rand J., Farrow H., Fleeman L., et al. Diet in the prevention of diabetes and obesity in companion animals. Asia Pac J Clin Nutr 12 suppl (2003) S6
18. Pierson L. Making cat food. Available from: (2007).
19. Ihaka R., and Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 5 (1996) 299-314
20. Shapiro S.S., and Wilk M.B. An analysis of variance test for normality (complete samples). Biometrika (1965) 591-611
21. Dohan F.C., and Lukens F.D. Experimental diabetes produced by the administration of glucose. Endocrinology 42 (1948) 244-262
22. Kaneto H., Katakami N., Kawamori D., et al. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal 9 (2007) 355-366
23. Zini E., Osto M., Franchini M., et al. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 52 (2009) 336-346
24. Mealey B.L., and Oates T.W. Diabetes mellitus and periodontal diseases. J Periodontol 77 (2006) 1289-1303
25. Casella M., Hassig M., and Reusch C.E. Home-monitoring of blood glucose in cats with diabetes mellitus: evaluation over a 4-month period. J Feline Med Surg 7 (2005) 163-171
26. Reusch C.E., Kley S., and Casella M. Home monitoring of the diabetic cat. J Feline Med Surg 8 (2006) 119-127
27. Rand J.S., Kinnaird E., Baglioni A., et al. Acute stress hyperglycemia in cats is associated with struggling and increased concentrations of lactate and norepinephrine. J Vet Intern Med 16 (2002) 123-132
28. Fonseca V., Bell D.S., Berger S., et al. A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study. Am J Med Sci 328 (2004) 274-280
29. Fulcher G.R., Gilbert R.E., and Yue D.K. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Intern Med J 35 (2005) 536-542
30. Cohen T., Nelson R., Kass P., et al. Evaluation of six portable blood glucose meters in dogs (2008), ACVIM, San Antonio, Texas, USA p 43
31. D'Orazio P., Burnett R.W., Fogh-Andersen N., et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem 51 (2005) 1573-1576
32. Steffes M.W., and Sacks D.B. Measurement of circulating glucose concentrations: the time is now for consistency among methods and types of samples. Clin Chem 51 (2005) 1569-1570
33. Coldman M.F., and Good W. The distribution of sodium, potassium and glucose in the blood of some mammals. Comp Biochem Physiol 21 (1967) 201-206
34. Mackay E. The distribution of glucose in human blood. J Biol Chem (1932) 685-688